A risky business: the detection of adverse drug reactions in clinical trials and post-marketing exercises.
暂无分享,去创建一个
[1] J. Abraham,et al. Democracy, Technocracy, and the Secret State of Medicines Control: Expert and Nonexpert Perspectives , 1997, Science, technology & human values.
[2] H. Marks,et al. Reviews: Medicine and Health-The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 , 1997 .
[3] A M Adelstein,et al. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. , 1969, Lancet.
[4] B. Culliton,et al. Post-marketing surveillance. , 1980, British medical journal.
[5] M D Rawlins,et al. Study of United Kingdom product licence applications containing new active substances, 1987-9. , 1991, BMJ.
[6] A. Ralston. Side effect , 2003 .
[7] J. Abraham. Science, politics, and the pharmaceutical industry , 1995 .
[8] P. Taylor-Gooby. Risk, trust and welfare , 2000 .
[9] T. Morris,et al. The meaning of medication. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.
[10] M. A. Elston,et al. The sociology of medical science and technology , 1999 .
[11] W. Inman,et al. Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. , 1968, British medical journal.
[12] B. Latour. Science in Action , 1987 .
[13] Munir Pirmohamed,et al. Fortnightly review: Adverse drug reactions , 1998 .
[14] J. Abraham,et al. The therapeutic nightmare: the battle over the world's most controversial sleeping pill , 1999 .
[15] R. Merkatz. Inclusion of women in clinical trials: a historical overview of scientific, ethical, and legal issues. , 1998, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.
[16] E. Snell,et al. Medical research on normal volunteers [letter] , 1986 .
[17] J. Avorn. Including elderly people in clinical trials , 1997, BMJ.
[18] R J Lilford,et al. Equipoise and the ethics of randomization. , 1995, Journal of the Royal Society of Medicine.
[19] Claire Gilbert Foster,et al. International ethical guidelines for biomedical research involving human subjects , 1994 .
[20] Atkin Pa,et al. Medication-related adverse reactions and the elderly: a literature review. , 1995 .
[21] J. Griffin,et al. The textbook of pharmaceutical medicine , 2005 .
[22] Ivan Illich,et al. Limits to medicine , 1976 .
[23] C. Medawar. Power And Dependence , 1993 .
[24] P Conrad,et al. The meaning of medications: another look at compliance. , 1985, Social science & medicine.
[25] H. Conjeevaram,et al. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. , 1995, The New England journal of medicine.
[26] N. Etkin. Side effects: cultural constructions and reinterpretations of western pharmaceuticals. , 1992 .
[27] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .